[
  {
    "ts": null,
    "headline": "Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains.",
    "summary": "The biotech sector is facing a pivotal moment, after a frustrating year of stalled rallies.  A look at the widely followed industry benchmark  exchange-traded fund (ticker: XBI) shows just how frustrating price action has been for investors so far in 2025.",
    "url": "https://finnhub.io/api/news?id=44030e8d5a6722e93dc61c093ed234796352ad4eaabd1c969d034e09e9608151",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753893420,
      "headline": "Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains.",
      "id": 136149057,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The biotech sector is facing a pivotal moment, after a frustrating year of stalled rallies.  A look at the widely followed industry benchmark  exchange-traded fund (ticker: XBI) shows just how frustrating price action has been for investors so far in 2025.",
      "url": "https://finnhub.io/api/news?id=44030e8d5a6722e93dc61c093ed234796352ad4eaabd1c969d034e09e9608151"
    }
  },
  {
    "ts": null,
    "headline": "Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out for",
    "summary": "MannKind (MNKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=22f6b22c47170befcdccf13203b3eb1dec50073004c4690c64894129b93fbde1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753884038,
      "headline": "Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out for",
      "id": 136149058,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "MannKind (MNKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=22f6b22c47170befcdccf13203b3eb1dec50073004c4690c64894129b93fbde1"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Gears Up to Report Q2 Earnings: Will the Beat Streak Continue?",
    "summary": "AMGN eyes another earnings beat as strong drug volumes offset pricing pressure and biosimilar headwinds.",
    "url": "https://finnhub.io/api/news?id=19034d13bf094b27d4de87764a7573cbe67d98efb9d9110d48e200f5cf68d1af",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753880100,
      "headline": "Amgen Gears Up to Report Q2 Earnings: Will the Beat Streak Continue?",
      "id": 136149059,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "AMGN eyes another earnings beat as strong drug volumes offset pricing pressure and biosimilar headwinds.",
      "url": "https://finnhub.io/api/news?id=19034d13bf094b27d4de87764a7573cbe67d98efb9d9110d48e200f5cf68d1af"
    }
  },
  {
    "ts": null,
    "headline": "Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates",
    "summary": "Anika (ANIK) delivered earnings and revenue surprises of 0.00% and +4.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=851534dac93fc1b1f37c2cf3ff1949752899a399453710ab4a16fd371c415161",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753877702,
      "headline": "Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates",
      "id": 136129968,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Anika (ANIK) delivered earnings and revenue surprises of 0.00% and +4.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=851534dac93fc1b1f37c2cf3ff1949752899a399453710ab4a16fd371c415161"
    }
  }
]